Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1076-1089

  Duncan, Gary E ^a   Knapp, Darin J ^b   Johnson, Kevin B ^b   Breese, George R ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MIANSERIN; NISOXETINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG CLASSIFICATION; DRUG MECHANISM; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; STRESS; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEOXYGLUCOSE; IMIPRAMINE; MALE; PRAZOSIN; PROPRANOLOL; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SWIMMING;

EID: 0030423668     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. ANISMAN, H. ANDZACHARKO, R. M.: Depression: The predisposing influence of stress. Behav. Brain Sci. 5: 89-137, 1982.
2. ARNOLD F. J. L., DE LUCAS BUENO, M., SHIERS, H., HANCOCK, D. C., EVAN, G. I. AND HERBERT, J.: Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats. Neuroscience 51: 377-390, 1992.
3. BAKER, G. B. ANDGREENSHAW, A. J.: Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell. Mol. Neurobiol. 9: 1-44, 1989.
4. BANKI, C. M., BISSETTE, G., ARATO, M., O'CONNOS, L. ANDNEMEROFF, C. B.: CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J. Psychiatry 144: 873-877, 1987.
5. BECK, C. H. M. ANDFIBIGER, H. C.: Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-fos. Pharmacol. Biochem. Behav. 51: 331-338, 1995.
6. BING, G., FILER, D., MILLER, J. C. ANDSTONE, E. A.: Noradrenergic activation of immediate early genes in the rat cerebral cortex. Mol. Brain Res. 11: 43-46, 1991.
7. BING, G., STONE, E. A., ZHANG, Y. ANDFILER, D.: Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS. Brain Res. 592: 57-62, 1992.
8. 14C-2-deoxyglucose autoradiography. J. Neurosci. 8: 1951-1961, 1988.
9. CARROLL, B. J., CURTIS, G. C., DAVIES, B. M., MENDELS, J. ANDSUCERMAK, A. A.: Urinary free cortisol excretion in depression. Psychol. Med. 6: 43-50, 1976.
10. CULLINAN, W. E., HERMAN, J. P., BATTAGLIA, D. F., AKIL, H. ANDWATSON, S. J.: Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64: 477-505, 1995.
11. CUMMINGS, S. ANDSEYBOLD, V.: Relationship of alpha-1 and alpha-2 adrenergic binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. Neuroendocrinology 47: 523-532, 1988.
12. DREVETS, W. C. ANDRAICHLE, M. E.: Neuroanatomical circuits in depression: Implications for treatment mechanisms. Psychopharmacol. Bull. 28: 261-274, 1992.
13. DREVETS, W. C., VIDEEN, T. O., PRICE, J. L., PRESKORN, S. H. ANDCARMICHAEL, S. T.: A functional anatomical study of unipolar depression, J. Neurosci. 12: 3628-3641, 1992.
14. DUNCAN, G. E.: High resolution autoradiographic imaging of brain activity patterns with 2-deoxyglucose: Regional topographic and cellular analysis. In NATO Advanced Science Institute Series, Vol. 68, ed. by F. Gonzalesz-Lima, Th. Finkenstadt, and H Scheich. Kluwer, Dordrecht, 1992.
15. DUNCAN, G. E., BREESE, G. R., CRISWELL, H. E., STUMPF, W. E., MUELLER, E. A. AND COVEY, J. B.: Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. J. Pharmacol. Exp. Ther. 238: 758-762, 1986.
16. DUNCAN, G. E., JOHNSON, K. B. ANDBREESE, G. R.: Topographic patterns of brain activity in response to swim stress: Assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J. Neurosci. 13: 3932-3943, 1993.
17. DUNCAN, G. E., KNAPP, D. J. ANDBREESE, G. R.: Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. (in press, 1996)
18. DUNCAN G. E., KNAPP, D. J., LITTLE, K. Y. ANDBREESE, G. R.: Neuroanatomical specificity and dose dependency in the time course of imipramine-induced β-adrenergic receptor down-regulation. J. Pharmacol. Exp. Ther. 271: 1699-1704, 1994.
19. DUNCAN, G. E., PAUL, I. A., HARDEN, K. T. MUELLER, R. A., STUMPF, W. E. AND BREESE, G. R : Rapid down regulation of β-adrenergic receptors by combining antidepressant drugs with forced swim: A model of antidepressant-induced neural adaptation. J. Pharmacol. Exp. Ther. 234: 402-408, 1985.
20. DUNCAN, G. E. ANDSTUMPF, W. E.: High resolution autoradiographic imaging of brain activity patterns with radiolabled 2-deoxyglucose. Methods Neurosci. 3: 50-64, 1990.
21. DUNCAN, G. E. ANDSTUMPF, W. E.: Brain activity patterns: Assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake. Prog. Neurobiol. 37: 365-382, 1991.
22. ETTIGI, P. G. ANDBROWN, G. M.: Psychoneuroendocrinology of affective disorders: an overview. Am. J. Psychiat. 134: 493-501, 1977.
23. FULLER, R. W., SNODDY, H. D. ANDMOLLOY, B. B.: Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. Psychopharmacol. Commun. 1: 455-464, 1975.
24. GUBITS, R. M., SMITH, T. M., FAIRHURST, J. L., HONG, Y.: Adrenergic receptors mediate changes in c-fos mRNA levels in brain. Brain Res. 6: 39-45, 1989.
25. JOHNSON, K. B., CRISWELL, H. E., JENSEN, K. F., SIMSON, P. E., MUELLER, R. A. AND BREESE, G R : Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-OHDA-lesioned rats: Behavioral effects and induction of Fos immunoreactivity. J. Pharmacol. Exp. Ther. 262: 855-865, 1992.
26. KATZ, R. J.: Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Phamacol. Biochem. Behav. 16: 965-968, 1982.
27. KATZ, R. J., ROTH, K. A. ANDCARROLL, B. J.: Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression. Neurosci. Biobehav. Rev. 5: 247-251, 1981.
28. KATZ, M. M., KOSLOW, S. H , MAAS, J., FRAZER, A., SECUNDA, S., BOWDEN, C. L., CASPER, R. C., CROUGHAN, J., KOCSIS, J., REDMOND E.: The timing, specificity, and clinical prediction of tricyclic drug effects in depression. Psychol Med. 17: 297-309, 1987.
29. KLEIN, D. F. ANDDAVIS, J. M.: Diagnosis and drug treatment in psychiatric disorders. Williams & Wilkins Co. Baltimore, 1969.
30. LEIBOWITZ, M. R., QUITKIN, F. M., STEWART, J. W., MCGRATH, P. J., HARRISON, W. M., MARKOWITZ, J. S., RABKIN, J. G., TRICAMO, E., GOETZ, D. M. ANDKLEIN, D. F.: Antidepressant specificity in atypical depression. Arch. Gen. Psychiat. 45: 129-137, 1988.
31. LINKOWSKI, P., MENDLEWICZ, J., KERKHOFS, M., LECLERCQ, R., GOLSTEIN, J., BRASSEUR, M., COPINSCHI, G. ANDVAN CAUTER, E.: 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J. Clin Endo. Metab. 65: 141-152, 1987.
32. LITTLE, K. Y., DUNCAN, G. E. ANDBREESE, G. R.: Autoradiographic analysis of beta-adrenergic receptor distribution in the human and rat hypothalamus. Biol. Psychiat. 32: 512-522, 1992.
33. MANN, E. ANDENNA, S. J.: Neurochemical and behavioral correlates of antidepressant drugs action. Life Sci. 30: 1653-1661, 1982.
34. MORGAN, J. L. ANDCURRAN, T.: Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogensens fos and jun. Ann Rev. Neurosci. 14: 421-451, 1991.
35. MORINOBU, S., NIBUYA, M. ANDDUMAN, R. S.: Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology 12: 221-228, 1995.
36. NEMEROFF, C. B., WIDERLOV, E., BISSETTE, G., WALLEUS, H., KIRLSSON, I., EKLUND, K, KLITS, C. D., LOOSEN, P. T. ANDVALE, W.: Elevated concentrations of CSF corticotrophin-releasing factor-like immunoreactivity in depressed patients. Science 226: 1342-1344, 1984
37. 125I-iodopindolol to β-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J Pharmacol. Exp. Ther. 257: 681-690, 1991
38. PAUL, I. A., DUNCAN, G. E., KUHN, C., MUELLER, R. A., HONG, J. S. ANDBREESE, G. R.: Neural adaptation in imipramine-treated rats processed in forced swim test: Assessment of time course, handling, rat strain and amine uptake. J. Pharmacol. Exp. Ther. 252: 997-1005, 1990.
39. PETTY, F. ANDSHERMAN, A. D.. Reversal of learned helplessness by imipramine. Commun. Psychopharmacol. 3: 371-373, 1979.
40. PEZZONE, M. A., LEE, W. S., HOFFMAN, G. E., RABIN, B. S.: Induction of Fos immunoreactivity in the forebrain by conditioned and unconditioned avergive stimuli. Brain Res. 597: 41-50, 1992.
41. PORSOLT, R. D., ANTON, A., BLAVET, N. ANDJALFRE, M.: Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47: 379-391, 1978.
42. QUITKIN, F. M., HARRISON, W., STEWART, J. W , MCGRATH, P. J., TICAMO, E., OCEPEK-WELIKSON, K., NUNES, E., AND KLEIN, D F.: Response to phenelzine versus imipramine in placebo non-responders with atypical depression Arch. Gen Psychiat. 48: 319-323, 1991.
43. RANDRUP, A. ANDBRAESTRUP, C.: Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology 53: 308-314, 1977.
44. REIMHERR, R. W., WOOD, D. R., BYERLEY, B., BRAINAKD, J. ANDGROSSER, B. I.: Characteristics of responders to fluoxetine. Psychopharmacol. Bull. 20: 70-72, 1984.
45. SACHAR, E. J.: Neuroendocrine abnormalities in depressive illness. In Topics in Psychoendocrinology, ed. by E. J. Sachar, pp 256-298, Grune and Stratton, New York, 1975.
46. SEGAL, Z. V., SHAW, B F., VELLA, D. D. ANDKATZ, R.: Cognitive and life stress predictors of relapse in remitted unipolar depressed patients: Test of the congruency hypothesis. J. Abnorm. Psychol. 101: 26-36, 1992
47. 14C) 2-deoxyglucose uptake in the caudal cerebellum of the rat during motor/sensory cortex stimulation. J Comp. Neurol. 284: 621-636, 1989.
48. SHENG, M. ANDGREENBERG, M. E.: The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4: 477-485, 1990.
49. SHERMAN, A. D. ANDPETTY, F.: Neurochemical basis of the action of antidepressants on learned helplessness. Behav. Neur. Biol. 30: 119-134, 1980.
50. SOUETRE, E., SALVATI, E., BELUGOU, J. L., PRINGUEY, D., CANDITO, M., KREBS, B., ARDISSON, J. L. ANDDASCOURT, G.: Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality. Psych. Res. 28: 263-278, 1989.
51. 14C) deoxyglucose method for the measurement of local cerbral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897-916, 1977.
52. STARK, P., FULLER, R. W. ANDWONG, D. T.: The pharmacologic profile of fluoxetine. J. Clin. Psychiatry 46: 7-13, 1985.
53. STEIGER, A., VON BARDELEBEN, V., HERTH, T. ANDHOLSBOER, F.: Sleep electroencephalogram and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J. Affect. Dis. 16: 189-195, 1989.
54. STEWART, J. W., MCGRATH, P. J., QUITIKIN, F. M., HARRISON, W., MARKOWWITZ, J., WAGER, S. ANDLEIBOWITZ, M. R.: Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Arch. Gen. Psychiat. 46: 1080-1087, 1989.
55. SWANSON, L. W. ANDHARTMAN, B. K.: The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine β-hydroxylase as a marker. J. Comp. Neurol. 163: 467-503, 1975.
56. WEISS, J. M., GOODMAN, P. A., LOSITO, B. G., CORRIGAN, S., CHARRY, J. M. AND BAILEY, W.: Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. Rev 3: 167-205, 1981.
57. WEISS, J. M. ANDSIMSON, P. E.: Neurochemical and electrophysiological events underlying stress-induced depression in an animal model. Adv. Exp. Med. Biol. 245: 425-440, 1988.
58. WILLNER, P.: Behavioral Models in Psychopharmacology: Theoretical, Industrial, and Clinical Perspectives. Cambridge University Press, Cambridge, 1991.
59. 3H-imipramine binding site Neuropharmacology 25: 519-525, 1986.